Some effects of chronic antidepressant treatments on rat brain monoaminergic systems
- 1 December 1983
- journal article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 57 (4) , 281-295
- https://doi.org/10.1007/bf01248999
Abstract
A range of established and putative antidepressant therapies were studied for the effect of their long-term administration on two facets of presynaptic monoaminergic functioning in rat brain, namely NE, DA, and 5-HT turnover and alpha2-adrenoceptor sensitivity. Unless stated otherwise drugs (10 mg/kg) were injected i.p. twice daily for 14 days. ECT (100 mA for 1 s) was applied once daily for 10 days. Changes in turnover were indirectly assessed by measuring levels of metabolites. Brain levels of MHPG-SO4 were unchanged by chronic amitriptyline, imipramine, nisoxetine (20 mg/kg), nortriptyline, salbutamol (5 mg/kg), and ECT. Amitriptyline elicited a slight, but significant, increase in brain DOPAC content. Brain levels of 5-HIAA were increased by amitriptyline, imipramine, salbutamol, and ECT. An overall view of the results indicates that no common pattern of change was elicited by the range of antidepressant therapies studied. Central alpha2-adrenoceptor sensitivity was assessed by investigating the effect of various therapies on the ability of clonidine (25μg/kg i.p.) to decrease rat brain MHPG-SO4 content. The clonidine-induced fall was attenuated by desipramine, imipramine, and ECT. Amitriptyline, iprindole, mianserin, nisoxetine, nortriptyline, Org 6582 (10 mg/kg once daily), pargyline (25 mg/kg once daily), salbutamol, and trazodone were ineffective. The following chronic antidepressant therapies were investigated for their effect on rat frontal cortex3H-clonidine binding: amitriptyline, desipramine, imipramine, iprindole, mianserin, nisoxetine, nortriptyline, pargyline, salbutamol, and ECT. Chronic, but not acute, pargyline decreased3H-clonidine binding and this was due to a diminished number of binding sites. The induction of subsensitive presynaptic alpha2-adrenoceptors in rat brain is not a property common to all forms of antidepressant therapies. Hence it cannot be the fundamental mode of action of antidepressants. No correlation exists between the changes in rat cortical3H-clonidine binding and the observed changes in the sensitivity of central presynaptic alpha2- adrenoceptors.Keywords
This publication has 47 references indexed in Scilit:
- Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioningPharmacology & Therapeutics, 1983
- Current status of the biogenic amine theory of depressionNeurochemistry International, 1982
- The effects of acute and repeated treatment with salbutamol, a?-adrenoceptor agonist, on clonidine-induced hypoactivity in ratsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1982
- Sensitivityin vivo of central? 2-and opiate receptors after chronic treatment with various antidepressantsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1982
- Current concepts on the mechanisms of action of antidepressant drugsPharmacology & Therapeutics, 1981
- The effect of single and chronic administration of imipramine on clonidine-induced hypothermia in the ratLife Sciences, 1981
- Effects of acutely and chronically administered antidepressants on the clonidine-induced decrease in rat brain 3-methoxy-4-hydroxyphenylethylene-glycol sulphate content.Life Sciences, 1981
- Functional evidence for subsensitivity of noradrenergic α2 receptors after chronic desipramine treatmentLife Sciences, 1980
- Changes in rat brain monoamine turnover following chronic antidepressant administrationLife Sciences, 1980
- Blood and brain concentrations of imipramine, clomipramine and their monomethylated metabolites after oral and intramuscular administration in ratsJournal of Pharmacy and Pharmacology, 1977